Montium

Montium® 10 mg Tablet: Each film-coated tablet contains Montelukast Sodium USP equivalent to Montelukast 10 mg.

Montelukast controls asthma by preventing leukotriene activities.

Montelukast is indicated for the prophylaxis and chronic treatment of asthma and for prevention of exercise-induced bronchoconstriction and for the relief of symptoms of allergic rhinitis in adults and pediatric patients.

Adults (15 years of age or over): 10 mg tablet once daily in the evening.

Generally, Montelukast is well-tolerated. Side effects include dizziness, headache, diarrhoea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.

Montelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks (in case of status asthmaticus).

Patients with known aspirin sensitivity should continue avoidance of aspirin or other NSAIDs, while taking Montelukast.

Montelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no appropriate increase in adverse reactions.

There were no adverse experiences reported in the majority of overdose reports. The most frequent adverse experiences observed were thirst, mydriasis, hyperkinesia and abdominal pain. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g. remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring and institute supportive therapy, if required.

Store in a cool and dry place below 30º C. Protect from light.

Montium® 10 mg Tablet: Each box contains 3x10 film-coated tablets in Alu-Alu blister strips.